Viewing StudyNCT00912418



Ignite Creation Date: 2024-05-05 @ 9:33 PM
Last Modification Date: 2024-10-26 @ 10:06 AM
Study NCT ID: NCT00912418
Status: COMPLETED
Last Update Posted: 2020-03-02
First Post: 2009-06-01

Brief Title: Pilot Study for the Evaluation of the Efficacy of Vaccination With Autologous Tumor Cells Plus Granulocyte-macrophage Colony-stimulating Factor GM-CSF - in - Adjuvant Followed by Systemic Low-dose-interleukin-2 IL-2 Administration in Patients With High Risk Melanoma
Sponsor: Craig L Slingluff Jr
Organization: University of Virginia

Key Dates - Follows AllAPIJSON File Order

Start Date: 2000-05-01
Start Date Type: ACTUAL
Primary Completion Date: 2002-09-17
Primary Completion Date Type: ACTUAL
Completion Date: 2002-10-09
Completion Date Type: ACTUAL
First Submit Date: 2009-06-01
First Submit QC Date: June 2 2009
Study First Post Date: 2009-06-03
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2020-02-27
Last Update Post Date: 2020-03-02
Last Update Post Date Type: ACTUAL